The HCC Assistant Coder Workflow is a coder-focused version of the HCC Assistant, perfect for provider organizations that have coder assistants. It allows the coder team to pre-select HCC codes for the provider to approve at the point of care. ...
One strategy for early identification and treatment of hepatocellular carcinoma (HCC) is to institute a screening and surveillance program for patients at high risk. Screening is defined as the first testing, and surveillance as regular testing, of at-risk patients. Key risks associated with the de...
However, despite all of that, the interesting part is that we pretty much are all coming to agree that the BCLC is a great method or a great kind of cheat sheet that you can have in your hands to tell you what to do for every patient. Small disease, we take it out. Small disease...
Nik, this is a very exciting field. We really have quite a few interesting drugs for the first line as well as for the second line of treatment. On the other hand, this has been going on for more than a decade. We have made a lot of progress in the past decade. Perhaps we can ...
A Physician Assistant's Perspective: Treatment Planning in NRG1+ NSCLC and Pancreatic Cancer DNA vs RNA Sequencing in NSCLC and Pancreatic Cancer Current Approaches and Treatment Challenges in NRG1+ NSCLC and Pancreatic Cancer Dr Bekaii-Saab on the Role of Liquid and Tissue Biopsies for Newly Dia...
A Physician Assistant's Perspective: Treatment Planning in NRG1+ NSCLC and Pancreatic Cancer DNA vs RNA Sequencing in NSCLC and Pancreatic Cancer Current Approaches and Treatment Challenges in NRG1+ NSCLC and Pancreatic Cancer Dr Bekaii-Saab on the Role of Liquid and Tissue Biopsies for Newly Di...
A Physician Assistant's Perspective: Treatment Planning in NRG1+ NSCLC and Pancreatic Cancer DNA vs RNA Sequencing in NSCLC and Pancreatic Cancer Current Approaches and Treatment Challenges in NRG1+ NSCLC and Pancreatic Cancer Dr Bekaii-Saab on the Role of Liquid and Tissue...
A Physician Assistant's Perspective: Treatment Planning in NRG1+ NSCLC and Pancreatic Cancer DNA vs RNA Sequencing in NSCLC and Pancreatic Cancer Current Approaches and Treatment Challenges in NRG1+ NSCLC and Pancreatic Cancer Dr Bekaii-Saab on the Role of Liquid and Tissue Biopsies for Newly Dia...
Andrew Zhu, MD, PhD:Correct. Nikolaos Pyrsopoulos, MD, PhD:The question goes TKI then I/O, and of course they are desperate. They are asking you, the physician. Go back to the TKI as the third line of therapy? What’s your take? Or if somebody has gone from TKI to TKI, how do...